Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin versus naproxen for catamenial migraine
IRCT20121110011424N4Phase 2Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, double-blind trial of melatonin and naproxen in Catamenial Migraine (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoints: Headache severity, Headache frequency and 3 more. Started Aug 2018; status: completed.
02
Drugs
melatoninnaproxen
03
Conditions
Catamenial Migraine
Beyond the preview
Go deeper on IRCT20121110011424N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20121110011424N4.